1 |
Agarwal S, George J, Padhan RK, et al. Reduction in mortality in severe acute pancreatitis: a time trend analysis over 16 years[J]. Pancreatology, 2016, 16(2): 194. |
2 |
中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华消化外科杂志, 2021, 20(7): 730. |
3 |
Meher S, Mishra TS, Sasmal PK, et al. Role of biomarkers in diagnosis and prognostic evaluation of acute pancreatitis[J]. J Biomark, 2015, 2015: 519534. |
4 |
周仁伟, 刘鹏军. PDW、PLT、MPV及BISAP评分对急性胰腺炎病情程度的预测价值[J]. 热带医学杂志, 2017, 17(11): 1490. |
5 |
Arif A, Jaleel F, Rashid K. Accuracy of BISAP score in prediction of severe acute pancreatitis[J]. Pak J Med Sci, 2019, 35(4): 1008. |
6 |
吴县斌, 苏东星, 潘志刚, 等. BISAP、APACHEⅡ、Ranson评分在预测急性胰腺炎预后中价值对比分析[J]. 现代消化及介入诊疗, 2016, 21(2): 294. |
7 |
Papachristou GI, Muddana V, Yadav D, et al. Comparison of BISAP, Ranson's, APACHE-Ⅱ, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis[J]. Am J Gastroenterol, 2010, 105(2): 435. |
8 |
Sahu B, Abbey P, Anand R, et al. Severity assessment of acute pancreatitis using CT severity index and modified CT severity index: correlation with clinical outcomes and severity grading as per the revised atlanta classification[J]. Indian J Radiol Imaging, 2017, 27(2): 152. |
9 |
Riechers RG 2nd, Ramage A, Brown W, et al. Physician knowledge of the Glasgow Coma Scale[J]. J Neurotrauma, 2005, 22(11): 1327. |
10 |
Bledsoe BE, Casey MJ, Feldman J, et al. Glasgow coma scale scoring is often inaccurate[J]. Prehosp Disaster Med, 2015, 30(1): 46. |
11 |
Heim C, Schoettker P, Gilliard N, et al. Knowledge of Glasgow coma scale by air-rescue physicians[J]. Scand J Trauma Resusc Emerg Med, 2009, 17: 39. |
12 |
巩伟, 李泽宇, 邹益, 等. PLR、PDW联合BISAP评分对急性胰腺炎严重程度的预测价值[J]. 中国现代医生, 2021, 59(30): 62. |
13 |
Dancu GM, Popescu A, Sirli R, et al. The BISAP score, NLR, CRP, or BUN: which marker best predicts the outcome of acute pancreatitis?[J]. Medicine (Baltimore), 2021, 100(51): e28121. |
14 |
De Waele JJ, Delrue L, Hoste EA, et al. Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis: evaluation of a new scoring system[J]. Pancreas, 2007, 34(2): 185. |
15 |
孙兵, 施福田, 孟永前. 奥曲肽联合乌司他丁对急性胰腺炎患者血清脂肪酶、CRP及临床疗效影响研究[J]. 中国生化药物杂志, 2015, 35(12): 122. |
16 |
焦谦. Balthazar、CTSI、EPIC评分系统对评估重症急性胰腺炎预后的价值(附60例报告)[D]. 沈阳: 中国医科大学, 2013. |
17 |
Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis[J]. Radiology, 1990, 174(2): 331. |
18 |
Cheng T, Han TY, Liu BF, et al. Use of modified balthazar grades for the early prediction of acute pancreatitis severity in the emergency department[J]. Int J Gen Med, 2022, 15: 1111. |
19 |
Koutroumpakis E, Wu BU, Bakker OJ, et al. Admission hematocrit and rise in blood urea nitrogen at 24 h outperform other laboratory markers in predicting persistent organ failure and pancreatic necrosis in acute pancreatitis: a post hoc analysis of three large prospective databases[J]. Am J Gastroenterol, 2015, 110(12): 1707. |
20 |
蓝远强, 黄丽珍, 梁敏, 等. 血清学指标和相关评分系统预测及诊断急性胰腺炎严重程度的进展[J]. 现代消化及介入诊疗, 2020, 25(11): 1539. |
21 |
刘晓强. Ranson评分联合C反应蛋白对中重度急性胆源性胰腺炎分型的预测价值[J]. 黑龙江医学, 2021, 45(1): 10. |
22 |
吴永强, 赵景成. Ranson评分在高脂血症性急性胰腺炎病情严重程度评估中的应用价值[J]. 临床和实验医学杂志, 2022, 21(2): 222. |
23 |
白驹. 高龄重症肺炎患者血清过氧化物及过氧化水平及其临床意义[J]. 分子诊断与治疗杂志, 2017, 9(3): 191. |
24 |
Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system[J]. Crit Care Med, 1981, 9(8): 591. |
25 |
段群欢, 唐朝晖, 卿伯华. 入院时APACHEⅡ评分对重症急性胰腺炎发生深部真菌感染的判断价值[J]. 中国普外基础与临床杂志, 2012, 19(2): 197. |
26 |
齐衍濛, 刘业成, 朱华栋. Ranson评分对中重度高脂血症性急性胰腺炎分型的预测价值[J]. 协和医学杂志, 2019, 10(5): 489. |
27 |
唐丽娜, 梁明欣, 王海燕. 红细胞分布宽度、血清钙及其比值与急性胰腺炎近期预后的相关性[J]. 中国中西医结合消化杂志, 2019, 27(8): 578. |
28 |
侯运辉, 卢清龙, 王莹, 等. 红细胞分布宽度联合PCT对胰腺炎合并重症感染患者病情的评估[J]. 中华医院感染学杂志, 2017, 27(14): 3255. |
29 |
Abu Omar Y, Attar BM, Agrawal R, et al. Revised marshall score: a new approach to stratifying the severity of acute pancreatitis[J]. Dig Dis Sci, 2019, 64(12): 3610. |